Vascular consequences of intermittent hypoxia

Advances in Experimental Medicine and Biology

Volumn 618, Issue , 2007, Pages 69-84

  Morgan, Barbara J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Chemoreceptor reflex; Sleep apnea; Sympathetic nervous system; Vascular reactivity

Indexed keywords

8 ISOPROSTANE; NITRIC OXIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; BIOMECHANICS; CONFERENCE PAPER; CONTROLLED STUDY; HYPERTENSION; HYPOXIA; KIDNEY NERVE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SLEEP APNEA SYNDROME; VASCULAR DISEASE;

ANIMALIA;

ANOXIA; BLOOD VESSELS; HUMANS; HYPERTENSION;

EID: 58249124472     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-75434-5_6     Document Type: Conference Paper

References (107)

1. Allahdadi KJ, Walker BR and Kanagy NL. Augmented endothelin vasoconstriction in intermittent hypoxia-induced hypertension. Hypertension 45: 705-709, 2005.
2. Biesold D, Kurosawa M, Sato A and Trzebski A. Hypoxia and hypercapnia increase the sympathoadrenal medullary functions in anesthetized, artificially ventilated rats. Jpn J Physiol 39: 511-522, 1989.
3. Bisgard GE. Carotid body mechanisms in acclimatization to hypoxia. Respir Physiol 121: 237-246, 2000.
4. Bleeke T, Zhang H, Madamanchi N, Patterson C and Faber JE. Catecholamineinduced vascular wall growth is dependent on generation of reactive oxygen species. Circ Res 94: 37-45, 2004.
5. Brooks D, Horner RL, Kozar LF, Render-Teixeira CL and Phillipson EA. Obstructive sleep apnea as a cause of systemic hypertension. Evidence from a canine model. J Clin Invest 99: 106-109, 1997.
6. Carlson JT, Hedner J, Elam M, Ejnell H, Sellgren J and Wallin BG. Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. Chest 103: 1763-1768, 1993.
7. Carmeliet P and Jain RK. Angiogenesis in cancer and other diseases. Nature 407: 249-257, 2000.
8. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E and Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124: 1386-1392, 2003.
9. Caudill TK, Resta TC, Kanagy NL and Walker BR. Role of endothelial carbon monoxide in attenuated vasoreactivity following chronic hypoxia. Am J Physiol 275: R1025-R1030, 1998.
10. Chen J, He L, Dinger B and Fidone S. Cellular mechanisms involved in rabbit carotid body excitation elicited by endothelin peptides. Respir Physiol 121: 13-23, 2000.
11. Chen J, He L, Dinger B, Stensaas L and Fidone S. Role of endothelin and endothelin A-type receptor in adaptation of the carotid body to chronic hypoxia. Am J Physiol Lung Cell Mol Physiol 282: L1314-L1323, 2002.
12. Cutler MJ, Swift NM, Keller DM, Wasmund WL and Smith ML. Hypoxia-mediated prolonged elevation of sympathetic nerve activity after periods of intermittent hypoxic apnea. J Appl Physiol 96: 754-761, 2004.
13. Dick TE, Hsieh YH, Wang N and Prabhakar N. Acute intermittent hypoxia increases both phrenic and sympathetic nerve activities in the rat. Exp Physiol 92: 87-97, 2007.
14. Doyle MP and Walker BR. Attentuation of systemic vasoreactivity in chronically hypoxic rats. Am J Physiol 260: R1114-R1122, 1991.
15. Duyndam MC, Hulscher TM, Fontijn D, Pinedo HM and Boven E. Induction of vascular endothelial growth factor expression and hypoxia-inducible factor 1alpha protein by the oxidative stressor arsenite. J Biol Chem 276: 48066-48076, 2001.
16. Dzau VJ. Theodore Cooper Lecture: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 37: 1047-1052, 2001.
17. Earley S, Naik JS and Walker BR. 48-h Hypoxic exposure results in endotheliumdependent systemic vascular smooth muscle cell hyperpolarization. Am J Physiol Regul Integr Comp Physiol 283: R79-R85, 2002.
18. Earley S, Pastuszyn A and Walker BR. Cytochrome p-450 epoxygenase products contribute to attenuated vasoconstriction after chronic hypoxia. Am J Physiol Heart Circ Physiol 285: H127-H136, 2003.
19. Earley S and Walker BR. Endothelium-dependent blunting of myogenic responsiveness after chronic hypoxia. Am J Physiol Heart Circ Physiol 283: H2202-H2209, 2002.
20. Earley S and Walker BR. Increased nitric oxide production following chronic hypoxia contributes to attenuated systemic vasoconstriction. Am J Physiol Heart Circ Physiol 284: H1655-H1661, 2003.
21. El Solh AA, Saliba R, Bosinski T, Grant BJ, Berbary E and Miller N. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 27: 997-1002, 2006.
22. Fletcher EC, Bao G and Li R. Renin activity and blood pressure in response to chronic episodic hypoxia. Hypertension 34: 309-314, 1999.
23. Fletcher EC, Lesske J, Culman J, Miller CC and Unger T. Sympathetic denervation blocks blood pressure elevation in episodic hypoxia. Hypertension 20: 612-619, 1992.
24. Fletcher EC, Lesske J, Qian W, Miller CC, III and Unger T. Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats. Hypertension 19: 555-561, 1992.
25. Fletcher EC, Orolinova N and Bader M. Blood pressure response to chronic episodic hypoxia: the renin-angiotensin system. J Appl Physiol 92: 627-633, 2002.
26. Foster GE, Hanly PJ, Ostrowski M and Poulin MJ. Effects of CPAP on Cerebral Vascular Response to Hypoxia in Obstructive Sleep Apnea Patients. Am J Respir Crit Care Med 2007.
27. Fredricks KT, Liu Y and Lombard JH. Response of extraparenchymal resistance arteries of rat skeletal muscle to reduced PO2. Am J Physiol 267: H706-H715, 1994.
28. Frisbee JC, Maier KG, Falck JR, Roman RJ and Lombard JH. Integration of hypoxic dilation signaling pathways for skeletal muscle resistance arteries. Am J Physiol Regul Integr Comp Physiol 283: R309-R319, 2002.
29. Frisbee JC, Roman RJ, Murali KU, Falck JR and Lombard JH. Altered mechanisms underlying hypoxic dilation of skeletal muscle resistance arteries of hypertensive versus normotensive Dahl rats. Microcirculation 8: 115-127, 2001.
30. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC and Stenmark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277: 44638-44650, 2002.
31. Gilmartin G, Tamisier R, Anand A, Cunnington D and Weiss JW. Evidence of impaired hypoxic vasodilation after intermediate-duration hypoxic exposure in humans. Am J Physiol Heart Circ Physiol 291: H2173-H2180, 2006.
32. Gladwin MT. Role of the red blood cell in nitric oxide homeostasis and hypoxic vasodilation. Adv Exp Med Biol 588: 189-205, 2006.
33. Goerre S, Wenk M, Bartsch P, Luscher TF, Niroomand F, Hohenhaus E, Oelz O and Reinhart WH. Endothelin-1 in pulmonary hypertension associated with high-altitude exposure. Circulation 91: 359-364, 1995.
34. Gonzales RJ and Walker BR. Role of CO in attenuated vasoconstrictor reactivity of mesenteric resistance arteries after chronic hypoxia. Am J Physiol Heart Circ Physiol 282: H30-H37, 2002.
35. Gonzalez NC, Allen J, Schmidt EJ, Casillan AJ, Orth T and Wood JG. Role of the renin-angiotensin system in the systemic microvascular inflammation of alveolar hypoxia. Am J Physiol Heart Circ Physiol 2007.
36. Greenberg HE, Sica A, Batson D and Scharf SM. Chronic intermittent hypoxia increases sympathetic responsiveness to hypoxia and hypercapnia. J Appl Physiol 86: 298-305, 1999.
37. Grote L, Kraiczi H and Hedner J. Reduced alpha- and beta(2)-adrenergic vascular response in patients with obstructive sleep apnea. Am J Respir Crit Care Med 162: 1480-1487, 2000.
38. Hansen J and Sander M. Sympathetic neural overactivity in healthy humans after prolonged exposure to hypobaric hypoxia. J Physiol 546: 921-929, 2003.
39. Hedner J, Ejnell H, Sellgren J, Hedner T and Wallin G. Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens Suppl 6: S529-S531, 1988.
40. Heindl S, Lehnert M, Criee CP, Hasenfuss G and Andreas S. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 164: 597-601, 2001.
41. Heistad DD, Abboud FM, Mark AL and Schmid PG. Impaired reflex vasoconstriction in chronically hypoxemic patients. J Clin Invest 51: 331-337, 1972.
42. Hirakawa H, Nakamura T and Hayashida Y. Effect of carbon dioxide on autonomic cardiovascular responses to systemic hypoxia in conscious rats. Am J Physiol 273: R747-R754, 1997.
43. Ip MS, Lam B, Chan LY, Zheng L, Tsang KW, Fung PC and Lam WK. Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162: 2166-2171, 2000.
44. Ip MS, Tse HF, Lam B, Tsang KW and Lam WK. Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169: 348-353, 2004.
45. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L and Michel JB. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) 49: 326-332, 2001.
46. Kanagy NL, Walker BR and Nelin LD. Role of endothelin in intermittent hypoxiainduced hypertension. Hypertension 37: 511-515, 2001.
47. Kato M, Roberts-Thomson P, Phillips BG, Haynes WG, Winnicki M, Accurso V and Somers VK. Impairment of endothelium-dependent vasodilation of resistance vessels in patients with obstructive sleep apnea. Circulation 102: 2607-2610, 2000.
48. Kraiczi H, Caidahl K, Samuelsson A, Peker Y and Hedner J. Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. Chest 119: 1085-1091, 2001.
49. Kraiczi H, Hedner J, Peker Y and Carlson J. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol 89: 493-498, 2000.
50. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D and Prabhakar NR. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575: 229-239, 2006.
51. Lam SY, Fung ML and Leung PS. Regulation of the angiotensin-converting enzyme activity by a time-course hypoxia in the carotid body. J Appl Physiol 96: 809-813, 2004.
52. Lam SY and Leung PS. A locally generated angiotensin system in rat carotid body. Regul Pept 107: 97-103, 2002.
53. Lattimore JL, Wilcox I, Skilton M, Langenfeld M and Celermajer DS. Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation. Thorax 61: 491-495, 2006.
54. Lawrence DL, Skatrud JB and Shenker Y. Effect of hypoxia on atrial natriuretic factor and aldosterone regulation in humans. Am J Physiol 258: E243-E248, 1990.
55. Lesske J, Fletcher EC, Bao G and Unger T. Hypertension caused by chronic intermittent hypoxia - influence of chemoreceptors and sympathetic nervous system. J Hypertens 15: 1593-1603, 1997.
56. Leuenberger U, Jacob E, Sweer L, Waravdekar N, Zwillich C and Sinoway L. Surges of muscle sympathetic nerve activity during obstructive apnea are linked to hypoxemia. J Appl Physiol 79: 581-588, 1995.
57. Liu JL, Murakami H and Zucker IH. Angiotensin II-nitric oxide interaction on sympathetic outflow in conscious rabbits. Circ Res 82: 496-502, 1998.
58. Logan AG, Perlikowski SM, Mente A, Tisler A, Tkacova R, Niroumand M, Leung RS and Bradley TD. High prevalence of unrecognized sleep apnoea in drug-resistant hypertension. J Hypertens 19: 2271-2277, 2001.
59. Minoguchi K, Yokoe T, Tazaki T, Minoguchi H, Tanaka A, Oda N, Okada S, Ohta S, Naito H and Adachi M. Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 172: 625-630, 2005.
60. Moller DS, Lind P, Strunge B and Pedersen EB. Abnormal vasoactive hormones and 24-hour blood pressure in obstructive sleep apnea. Am J Hypertens 16: 274-280, 2003.
61. Morgan BJ, Crabtree DC, Palta M and Skatrud JB. Combined hypoxia and hypercapnia evokes long-lasting sympathetic activation in humans. J Appl Physiol 79: 205-213, 1995.
62. Morgan BJ, Denahan T and Ebert TJ. Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74: 2969-2975, 1993.
63. Naik JS and Walker BR. Role of vascular heme oxygenase in reduced myogenic reactivity following chronic hypoxia. Microcirculation 13: 81-88, 2006.
64. Narkiewicz K, van de Borne PJ, Montano N, Dyken ME, Phillips BG and Somers VK. Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. Circulation 97: 943-945, 1998.
65. Nieto FJ, Herrington DM, Redline S, Benjamin EJ and Robbins JA. Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169: 354-360, 2004.
66. O'Donaughy TL and Walker BR. Renal vasodilatory influence of endogenous carbon monoxide in chronically hypoxic rats. Am J Physiol Heart Circ Physiol 279: H2908-H2915, 2000.
67. Oskarsson HJ and Heistad DD. Oxidative stress produced by angiotensin too. Implications for hypertension and vascular injury. Circulation 95: 557-559, 1997.
68. Peng YJ, Overholt JL, Kline D, Kumar GK and Prabhakar NR. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A 100: 10073-10078, 2003.
69. Peng YJ and Prabhakar NR. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol 94: 2342-2349, 2003.
70. Peppard PE, Young T, Palta M and Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342: 1378-1384, 2000.
71. Phillips BG, Narkiewicz K, Pesek CA, Haynes WG, Dyken ME and Somers VK. Effects of obstructive sleep apnea on endothelin-1 and blood pressure. J Hypertens 17: 61-66, 1999.
72. Phillips C, Hedner J, Berend N and Grunstein R. Diurnal and obstructive sleep apnea influences on arterial stiffness and central blood pressure in men. Sleep 28: 604-609, 2005.
73. Phillips SA, Olson EB, Lombard JH and Morgan BJ. Chronic intermittent hypoxia alters NE reactivity and mechanics of skeletal muscle resistance arteries. J Appl Physiol 100: 1117-1123, 2006.
74. Phillips SA, Olson EB, Morgan BJ and Lombard JH. Chronic intermittent hypoxia impairs endothelium-dependent dilation in rat cerebral and skeletal muscle resistance arteries. Am J Physiol Heart Circ Physiol 286: H388-H393, 2004.
75. Prabhakar NR and Jacono FJ. Cellular and molecular mechanisms associated with carotid body adaptations to chronic hypoxia. High Alt Med Biol 6: 112-120, 2005.
76. Prabhakar NR and Kumar GK. Oxidative stress in the systemic and cellular responses to intermittent hypoxia. Biol Chem 385: 217-221, 2004.
77. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK and Dick TE. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32: 447-449, 2005.
78. Ray CJ, Abbas MR, Coney AM and Marshall JM. Interactions of adenosine, prostaglandins and nitric oxide in hypoxia-induced vasodilatation: in vivo and in vitro studies. J Physiol 544: 195-209, 2002.
79. Remsburg S, Launois SH and Weiss JW. Patients with obstructive sleep apnea have an abnormal peripheral vascular response to hypoxia. J Appl Physiol 87: 1148-1153, 1999.
80. Rowell LB, Johnson DG, Chase PB, Comess KA and Seals DR. Hypoxemia raises muscle sympathetic activity but not norepinephrine in resting humans. J Appl Physiol 66: 1736-1743, 1989.
81. Saito M, Mano T, Iwase S, Koga K, Abe H and Yamazaki Y. Responses in muscle sympathetic activity to acute hypoxia in humans. J Appl Physiol 65: 1548-1552, 1988.
82. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162: 566-570, 2000.
83. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V and Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105: 2462-2464, 2002.
84. Sica AL, Greenberg HE, Ruggiero DA and Scharf SM. Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol 121: 173-184, 2000.
85. Steiner DR, Gonzalez NC and Wood JG. Interaction between reactive oxygen species and nitric oxide in the microvascular response to systemic hypoxia. J Appl Physiol 93: 1411-1418, 2002.
86. Stenmark KR, Gerasimovskaya E, Nemenoff RA and Das M. Hypoxic activation of adventitial fibroblasts: role in vascular remodeling. Chest 122: 326S-334S, 2002.
87. Sun MK and Reis DJ. Evidence nitric oxide mediates the vasodepressor response to hypoxia in sino-denervated rats. Life Sci 50: 555-565, 1992.
88. Sun SY, Wang W, Zucker IH and Schultz HD. Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure. J Appl Physiol 86: 1264-1272, 1999.
89. Sun TB, Yang CC, Lai CJ and Kuo TB. Time course of cardiovascular neural regulation during programmed 20-sec apnea in rats. Crit Care Med 34: 765-770, 2006.
90. Tahawi Z, Orolinova N, Joshua IG, Bader M and Fletcher EC. Altered vascular reactivity in arterioles of chronic intermittent hypoxic rats. J Appl Physiol 90: 2007-2013, 2001.
91. Tamisier R, Anand A, Nieto LM, Cunnington D and Weiss JW. Arterial pressure and muscle sympathetic nerve activity are increased after two hours of sustained but not cyclic hypoxia in healthy humans. J Appl Physiol 98: 343-349, 2005.
92. Tanriverdi H, Evrengul H, Kara CO, Kuru O, Tanriverdi S, Ozkurt S, Kaftan A and Kilic M. Aortic stiffness, flow-mediated dilatation and carotid intima-media thickness in obstructive sleep apnea: non-invasive indicators of atherosclerosis. Respiration 73: 741-750, 2006.
93. Touyz RM. Molecular and cellular mechanisms in vascular injury in hypertension: role of angiotensin II. Curr Opin Nephrol Hypertens 14: 125-131, 2005.
94. Tulis DA and Prewitt RL. Medial and endothelial platelet-derived growth factor A chain expression is regulated by in vivo exposure to elevated flow. J Vasc Res 35: 413-420, 1998.
95. Vaziri ND and Wang ZQ. Sustained systemic arterial hypertension induced by extended hypobaric hypoxia. Kidney Int 49: 1457-1463, 1996.
96. Weisbrod CJ, Minson CT, Joyner MJ and Halliwill JR. Effects of regional phentolamine on hypoxic vasodilatation in healthy humans. J Physiol 537: 613-621, 2001.
97. Weiss JW, Liu MD and Huang J. Sleep Apnoea & Hypertension: Physiological bases for a causal relation: Physiological basis for a causal relationship of obstructive sleep apnoea to hypertension. Exp Physiol 92: 21-26, 2007.
98. Williams AJ, Houston D, Finberg S, Lam C, Kinney JL and Santiago S. Sleep apnea syndrome and essential hypertension. Am J Cardiol 55: 1019-1022, 1985.
99. Wilson E, Mai Q, Sudhir K, Weiss RH and Ives HE. Mechanical strain induces growth of vascular smooth muscle cells via autocrine action of PDGF. J Cell Biol 123: 741-747, 1993.
100. Wolfel EE, Selland MA, Mazzeo RS and Reeves JT. Systemic hypertension at 4,300 m is related to sympathoadrenal activity. J Appl Physiol 76: 1643-1650, 1994.
101. Xie A, Skatrud JB, Crabtree DC, Puleo DS, Goodman BM and Morgan BJ. Neurocirculatory consequences of intermittent asphyxia in humans. J Appl Physiol 89: 1333-1339, 2000.
102. Xie A, Skatrud JB, Puleo DS and Morgan BJ. Exposure to hypoxia produces longlasting sympathetic activation in humans. J Appl Physiol 91: 1555-1562, 2001.
103. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T and Adachi M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107: 1129-1134, 2003.
104. Yu HJ, Lin BR, Lee HS, Shun CT, Yang CC, Lai TY, Chien CT and Hsu SM. Sympathetic vesicovascular reflex induced by acute urinary retention evokes proinflammatory and proapoptotic injury in rat liver. Am J Physiol Renal Physiol 288: F1005-F1014, 2005.
105. Zhao Q, Ishibashi M, Hiasa K, Tan C, Takeshita A and Egashira K. Essential role of vascular endothelial growth factor in angiotensin II-induced vascular inflammation and remodeling. Hypertension 44: 264-270, 2004.
106. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR and Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res 91: 1038-1045, 2002.
107. Zucker IH. Brain angiotensin II: new insights into its role in sympathetic regulation. Circ Res 90: 503-505, 2